Drug Profile
Polyadenylic polyuridylic acid
Alternative Names: BN 52101; PolyA PolyU; PolyadenurLatest Information Update: 04 Nov 2002
Price :
$50
*
At a glance
- Originator Ipsen
- Class Antineoplastics; Polyribonucleotides; Small molecules
- Mechanism of Action Immunostimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Breast cancer; Gastric cancer; Hepatitis B; HIV infections
Most Recent Events
- 04 Nov 2002 No development reported - Phase-II for Breast cancer in Spain (IV)
- 04 Nov 2002 No development reported - Phase-II for Gastric cancer in South Korea (IV)
- 04 Nov 2002 No development reported - Phase-II for Hepatitis B in South Korea (IV)